Medical Condition News

RSS

Early adulthood hypertension linked to heart and kidney disease later in life

Higher blood pressure during young adulthood is likely linked to a higher risk of heart disease and kidney disease later in life, reinforcing the importance of maintaining healthy blood pressure at younger ages, according to preliminary research presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026.

23 Mar 2026

Major UK clinical trial finds surfactant therapy ineffective for severe bronchiolitis

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis - a seasonal viral illness that hospitalizes thousands of babies each year.

23 Mar 2026

Scientists identify new target to slow Huntington’s disease progression

Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory and personality.

23 Mar 2026

Chronotherapy offers new hope for timing pain relief to match body cycles

Time plays a key role in our perception of pain and administering pain relief and medication for chronic pain-related depression may be more effective at certain times of day, UCL and University of Toronto researchers say.

23 Mar 2026

AI-assisted decision support system improves stroke care and long-term outcomes

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment recommendations is associated with better quality care and long term outcomes for patients compared with usual care, finds a study from China published by The BMJ today.

23 Mar 2026

Replacing sedentary time improves insulin resistance in adolescents

Adolescents who replaced just half an hour of sedentary behaviors, such as sitting on the couch or spending time at the computer, each day for moderate-to-vigorous physical activity or sleep may lower their insulin resistance, a key factor in preventing the development of Type 2 diabetes, according to preliminary research presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026.

23 Mar 2026

Early biomarker predicts cognitive impairment after out-of-hospital cardiac arrest

Routine early measurement of neurofilament light chain could help improve prediction of cognitive impairment after out-of-hospital cardiac arrest, according to a study presented today at ESC Acute CardioVascular Care 2026, the annual congress of the Association for Acute CardioVascular Care (ACVC), a branch of the European Society of Cardiology (ESC).

23 Mar 2026

Higher meat intake may slow cognitive decline in older adults with APOE ε4

In older Swedish adults, higher meat intake was associated with slower cognitive decline and lower dementia risk among people carrying APOE ε3/ε4 or ε4/ε4, but not among other genotype groups. A higher processed-to-total meat ratio was linked to worse dementia outcomes, while unprocessed red meat and poultry showed no substantial difference.

22 Mar 2026

Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trials

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in people with early symptomatic, amyloid-positive Alzheimer’s disease. Semaglutide was generally consistent with its known safety profile and showed some biomarker changes, but these did not translate into clinical benefit.

22 Mar 2026

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated with lower risks of major cardiovascular events and end-stage kidney disease over five years. The study also found no increased risk of hospitalization for diabetic ketoacidosis or severe hypoglycemia, supporting further randomized trials of GLP-1RAs as adjunctive therapy in type 1 diabetes.

22 Mar 2026

Study finds addiction risk tied to reward and impulse genes

Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process rewards, regulate impulses and weigh consequences – not from genes that specifically influence substance use disorder or any single drug.

22 Mar 2026

Losing health insurance worsens diabetes outcomes in low-income adults

Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University,

22 Mar 2026

‘How low can you go?’ The shifting guidelines for blood pressure control

The patient initially came to see Mark Supiano in 2017 because her family was concerned about her short-term memory loss.

20 Mar 2026

AI diet plans underestimate teen nutrition and miss key nutrients

AI tools for adolescent diet planning may fall short, consistently underestimating nutrient intake and energy needs compared to individualized dietitian plans.

20 Mar 2026

Study links gut microbiome imbalance to worsening kidney disease

Researchers at UC Davis School of Medicine have uncovered how an imbalanced gut microbiome escalates the production of metabolic byproducts by certain gut bacteria.

19 Mar 2026

Mandated caps reduce insulin out-of-pocket costs among US Medicare beneficiaries

A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health finds that out-of-pockets caps on insulin for Medicare Part D beneficiaries have reined in insulin prices.

19 Mar 2026

Brain age from sleep patterns may signal future dementia risk

A machine-learning analysis of brain waves recorded during sleep may help identify people at high risk of developing dementia, according to a study led by UC San Francisco and Beth Israel Deaconess Medical Center in Boston.

19 Mar 2026

Study identifies protein biomarker and potential treatment for schizophrenia

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction.

19 Mar 2026

Home-based chemotherapy proves to be safe and feasible in pilot study

In a study published in NEJM Catalyst, Mayo Clinic researchers have demonstrated that chemotherapy can be safely delivered in patients' homes.

19 Mar 2026

Urban living may reduce risk of first-time stroke

While urban life is often associated with stress and pollution, living in more intensely developed neighborhoods may actually protect against stroke, a new University of Michigan study suggests.

19 Mar 2026